GLP-1 receptors are found in the heart and blood vessels, influencing blood pressure, lipid profiles and inflammation
These results are roughly in line with what Lilly has demonstrated for tirzepatide (22.5% and 20.9% respectively at 72 weeks), but fall short of the 25% bar for efficacy many investors were anticipating, BMO Capital Markets analysts wrote in a note to investors
GLP-1 is a hormone naturally made in your body in response to (after) a meal, but in type 2 diabetes, its effect is reduced or no longer present
Lilly announced selfpay singledose vials for all doses via LillyDirect in June 2025
It is released in the gut in response to food intake and works to slow stomach emptying, which increases feelings of fullness
Animal studies indicate that GHK-Cu can significantly influence wound healing, immune function, and skin health by stimulating collagen production, promoting blood vessel growth, and supporting fibroblast activity